ENSC
Price
$0.90
Change
-$0.03 (-3.23%)
Updated
Jan 15, 11:03 AM (EDT)
Capitalization
3.38M
Intraday BUY SELL Signals
RLMD
Price
$3.83
Change
-$0.01 (-0.26%)
Updated
Jan 15, 12:03 PM (EDT)
Capitalization
281.6M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENSC vs RLMD

Header iconENSC vs RLMD Comparison
Open Charts ENSC vs RLMDBanner chart's image
Ensysce Biosciences
Price$0.90
Change-$0.03 (-3.23%)
Volume$120
Capitalization3.38M
Relmada Therapeutics
Price$3.83
Change-$0.01 (-0.26%)
Volume$100
Capitalization281.6M
ENSC vs RLMD Comparison Chart in %
ENSC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENSC vs. RLMD commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and RLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ENSC: $0.93 vs. RLMD: $3.84)
Brand notoriety: ENSC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 23% vs. RLMD: 42%
Market capitalization -- ENSC: $3.38M vs. RLMD: $281.6M
ENSC [@Biotechnology] is valued at $3.38M. RLMD’s [@Biotechnology] market capitalization is $281.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileRLMD’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • RLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENSC and RLMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 6 TA indicator(s) are bullish while RLMD’s TA Score has 3 bullish TA indicator(s).

  • ENSC’s TA Score: 6 bullish, 2 bearish.
  • RLMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ENSC is a better buy in the short-term than RLMD.

Price Growth

ENSC (@Biotechnology) experienced а -13.08% price change this week, while RLMD (@Biotechnology) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

RLMD is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($282M) has a higher market cap than ENSC($3.38M). ENSC YTD gains are higher at: 1.087 vs. RLMD (-20.497). ENSC has higher annual earnings (EBITDA): -10.95M vs. RLMD (-57.84M). RLMD has more cash in the bank: 13.9M vs. ENSC (1.67M). RLMD has less debt than ENSC: RLMD (256K) vs ENSC (388K). ENSC (0) and RLMD (0) have equivalent revenues.
ENSCRLMDENSC / RLMD
Capitalization3.38M282M1%
EBITDA-10.95M-57.84M19%
Gain YTD1.087-20.497-5%
P/E Ratio0.02N/A-
Revenue00-
Total Cash1.67M13.9M12%
Total Debt388K256K152%
FUNDAMENTALS RATINGS
ENSC vs RLMD: Fundamental Ratings
ENSC
RLMD
OUTLOOK RATING
1..100
5280
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9634
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (25) in the null industry is somewhat better than the same rating for RLMD (71). This means that ENSC’s stock grew somewhat faster than RLMD’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

ENSC's SMR Rating (100) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

RLMD's Price Growth Rating (34) in the null industry is somewhat better than the same rating for ENSC (96). This means that RLMD’s stock grew somewhat faster than ENSC’s over the last 12 months.

ENSC's P/E Growth Rating (77) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCRLMD
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JAGX0.760.07
+10.61%
Jaguar Health Inc
HE14.030.26
+1.89%
Hawaiian Electric Industries
KIM20.640.08
+0.39%
Kimco Realty Corp
HLLY4.190.01
+0.24%
Holley
KORE4.75-0.16
-3.26%
KORE Group Holdings

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with RLMD. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then RLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
+0.50%
RLMD - ENSC
41%
Loosely correlated
-5.42%
ITRM - ENSC
38%
Loosely correlated
-2.98%
MLLCF - ENSC
37%
Loosely correlated
N/A
RGNX - ENSC
36%
Loosely correlated
-0.66%
HNSBF - ENSC
33%
Loosely correlated
N/A
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENSC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
-5.42%
ENSC - RLMD
41%
Loosely correlated
+0.50%
PLUR - RLMD
37%
Loosely correlated
-5.15%
SYRE - RLMD
36%
Loosely correlated
+5.17%
PRTC - RLMD
31%
Poorly correlated
+4.81%
AVXL - RLMD
31%
Poorly correlated
+3.88%
More